| Product Code: ETC7645367 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Autoimmune Disease Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Autoimmune Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Autoimmune Disease Treatment Market - Industry Life Cycle |
3.4 Israel Autoimmune Disease Treatment Market - Porter's Five Forces |
3.5 Israel Autoimmune Disease Treatment Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Autoimmune Disease Treatment Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Autoimmune Disease Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Israel Autoimmune Disease Treatment Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.9 Israel Autoimmune Disease Treatment Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.10 Israel Autoimmune Disease Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.11 Israel Autoimmune Disease Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Israel Autoimmune Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Israel |
4.2.2 Technological advancements in autoimmune disease treatment |
4.2.3 Rising awareness about autoimmune diseases and available treatment options |
4.3 Market Restraints |
4.3.1 High treatment costs associated with autoimmune disease therapies |
4.3.2 Stringent regulatory requirements for drug approval in Israel |
5 Israel Autoimmune Disease Treatment Market Trends |
6 Israel Autoimmune Disease Treatment Market, By Types |
6.1 Israel Autoimmune Disease Treatment Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Autoimmune Disease Treatment Market Revenues & Volume, By B Cell Inhibitors, 2021- 2031F |
6.1.4 Israel Autoimmune Disease Treatment Market Revenues & Volume, By T Cell Inhibitors, 2021- 2031F |
6.1.5 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Tumor Necrosis Factor Inhibitors, 2021- 2031F |
6.1.6 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.1.7 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Immunosuppressants,, 2021- 2031F |
6.1.8 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Beta Interferons, 2021- 2031F |
6.1.9 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Autoimmune Disease Treatment Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Graves Disease, 2021- 2031F |
6.2.3 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.4 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Hashimotos Thyroiditis, 2021- 2031F |
6.2.5 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Vitiligo, 2021- 2031F |
6.2.6 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Type 1 Diabetes, 2021- 2031F |
6.2.7 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Pernicious Anemia, 2021- 2031F |
6.3 Israel Autoimmune Disease Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.3.4 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.3.5 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Pharmacies, 2021- 2031F |
6.3.6 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Autoimmune Disease Treatment Market, By Disease |
6.4.1 Overview and Analysis |
6.4.2 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Crohn's Disease, 2021- 2031F |
6.4.3 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.4.4 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Inflammatory Bowel Disease, 2021- 2031F |
6.4.5 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.4.6 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Systemic Lupus Erythematosus, 2021- 2031F |
6.4.7 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.5 Israel Autoimmune Disease Treatment Market, By Mechanism of Action |
6.5.1 Overview and Analysis |
6.5.2 Israel Autoimmune Disease Treatment Market Revenues & Volume, By TNF Inhibitors, 2021- 2031F |
6.5.3 Israel Autoimmune Disease Treatment Market Revenues & Volume, By IL Blockers, 2021- 2031F |
6.5.4 Israel Autoimmune Disease Treatment Market Revenues & Volume, By COX Inhibitors, 2021- 2031F |
6.5.5 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Phosphodiesterase Type 4 Inhibitors, 2021- 2031F |
6.5.7 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Diagnostic, 2021- 2031F |
6.5.8 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Antinuclear Antibody Tests, 2021- 2031F |
6.5.9 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Antinuclear Antibody Tests, 2021- 2031F |
6.6 Israel Autoimmune Disease Treatment Market, By Treatment |
6.6.1 Overview and Analysis |
6.6.2 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.6.3 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Physical Therapy, 2021- 2031F |
6.7 Israel Autoimmune Disease Treatment Market, By Product |
6.7.1 Overview and Analysis |
6.7.2 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Diagnostic Equipment, 2021- 2031F |
6.7.3 Israel Autoimmune Disease Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.7.4 Israel Autoimmune Disease Treatment Market Revenues & Volume, By , 2021- 2031F |
7 Israel Autoimmune Disease Treatment Market Import-Export Trade Statistics |
7.1 Israel Autoimmune Disease Treatment Market Export to Major Countries |
7.2 Israel Autoimmune Disease Treatment Market Imports from Major Countries |
8 Israel Autoimmune Disease Treatment Market Key Performance Indicators |
8.1 Number of patients diagnosed with autoimmune diseases in Israel |
8.2 Adoption rate of advanced autoimmune disease treatment technologies in the market |
8.3 Patient satisfaction and outcomes with autoimmune disease treatments |
8.4 Research and development investments in autoimmune disease therapies |
8.5 Rate of reimbursement for autoimmune disease treatments by healthcare payers |
9 Israel Autoimmune Disease Treatment Market - Opportunity Assessment |
9.1 Israel Autoimmune Disease Treatment Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Autoimmune Disease Treatment Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Autoimmune Disease Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Israel Autoimmune Disease Treatment Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.5 Israel Autoimmune Disease Treatment Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.6 Israel Autoimmune Disease Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.7 Israel Autoimmune Disease Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
10 Israel Autoimmune Disease Treatment Market - Competitive Landscape |
10.1 Israel Autoimmune Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Autoimmune Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here